Status:
COMPLETED
Patient Experiences With Virtual Reality Mindfulness Skills Training
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Brain & Behavior Research Foundation
Conditions:
Anxiety
Distress, Emotional
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to assess acceptability and preliminary efficacy of an intervention being administered clinically, a virtual reality (VR) mindfulness program. It is hypothesized that patients will fin...
Detailed Description
This pilot study proposes to assess acceptability and preliminary efficacy of an intervention being administered clinically, a virtual reality (VR) mindfulness program. Acceptability and preliminary e...
Eligibility Criteria
Inclusion
- Referred to psychology/neuropsychology
- Identified by treatment team for use of VR mindfulness intervention
- Able to provide informed consent or assent
- Patient is over the age of 18
Exclusion
- Has not engaged in VR mindfulness intervention.
- Determination by clinical team that patient cannot or would not benefit from participation in VR.
- Reasons may include history of severe motion sickness or seizures, history of destruction of property, visual disturbance, vertigo, and cognitive impairment, delirium, and current or past diagnosis of a psychotic disorder
Key Trial Info
Start Date :
May 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2023
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT05291533
Start Date
May 6 2022
End Date
August 18 2023
Last Update
April 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10065